A SENSITIVE AND REPRODUCIBLE HPLC ASSAY FOR DOXORUBICIN AND PIRARUBICIN

被引:20
作者
JACQUET, JM
GALTIER, M
BRESSOLLE, F
JOURDAN, J
机构
[1] FAC PHARM MONTPELLIER,DEPT PHARMACOCINET,AVE CHARLES FLAHAULT,F-34060 MONTPELLIER,FRANCE
[2] CTR HOSP & REG UNIV NIMES,FAC MED,UNIV THERAPEUT LAB,F-30006 NIMES,FRANCE
[3] CTR HOSP & REG UNIV NIMES,PHARMACOCINET LAB,F-30006 NIMES,FRANCE
关键词
DOXORUBICIN; PIRARUBICIN; DOXORUBICINOL; HPLC METHOD; BIOLOGICAL FLUIDS;
D O I
10.1016/0731-7085(92)80050-W
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A high-performance liquid chromatographic method with spectrofluorometric detection has been developed for the analysis of doxorubicin (DOX), pirarubicin (PIRA) and their metabolite, doxorubicinol, in plasma. The detection was performed at 480 nm for excitation, and 590 nm for emission. The proposed technique is selective, reliable, and sensitive. The limit of quantification was 2 ng ml-1 for DOX and 5 ng ml-1 for PIRA. The reproducibility of the analytical method through statistical coefficients is approximately 5%. The accuracy of the method is good; the relative error is <5%.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 13 条
[1]  
Arcamone F., 1981, DOXORUBICIN ANTICANC
[2]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC BIOANALYSIS OF ANTHRACYCLINE CYTOSTATIC DRUGS [J].
BEIJNEN, JH ;
UNDERBERG, WJM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1988, 6 (6-8) :677-685
[3]   RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE ANTHRACYCLINES DAUNORUBICIN AND 7-CON-O-METHYLNOGAROL IN PLASMA [J].
BROWN, JE ;
WILKINSON, PA ;
BROWN, JR .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02) :521-525
[4]  
CHAN KK, 1973, RES COMMUN CHEM PATH, V6, P447
[5]   LOW HEART AND SKIN TOXICITY OF A TETRAHYDROPYRANYL DERIVATIVE OF ADRIAMYCIN (THP-ADM) AS OBSERVED BY ELECTRON AND LIGHT-MICROSCOPY [J].
DANTCHEV, D ;
PAINTRAND, M ;
HAYAT, M ;
BOURUT, C ;
MATHE, G .
JOURNAL OF ANTIBIOTICS, 1979, 32 (10) :1085-1086
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF DOXORUBICIN IN TISSUES AFTER SOLID-PHASE EXTRACTION [J].
DEGROOT, G ;
TEPAS, BCA ;
STORM, G .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1988, 6 (6-8) :927-932
[7]  
FINKEL JM, 1969, CANCER CHEMOTH REP 1, V53, P159
[8]   DOXORUBICIN AND DOXORUBICINOL - INTRAINDIVIDUAL AND INTERINDIVIDUAL VARIATIONS OF PHARMACOKINETIC PARAMETERS [J].
JACQUET, JM ;
BRESSOLLE, F ;
GALTIER, M ;
BOURRIER, M ;
DONADIO, D ;
JOURDAN, J ;
ROSSI, JF .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (03) :219-225
[9]   IMPROVED METHOD FOR THE DETERMINATION OF 4'-EPIDOXORUBICIN AND 7 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
MAESSEN, PA ;
MROSS, KB ;
PINEDO, HM ;
VANDERVIJGH, WJF .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 417 (02) :339-346
[10]   MEASUREMENT OF ADRIAMYCIN (DOXORUBICIN) AND ITS METABOLITES IN HUMAN-PLASMA USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE DETECTION [J].
PIERCE, RN ;
JATLOW, PI .
JOURNAL OF CHROMATOGRAPHY, 1979, 164 (04) :471-478